Back to search

University of British Columbia

The strategic use of intellectual and industrial property laws to maintain and extend a dominant position in the pharmaceutical industry

Abstract

dc:description

It is assumed at the outset of this thesis that there is a public interest in the purchase of prescribed drugs at the lowest aggregate price consistent with the maintenace of reseach and development in the pharmaceutical field. The thesis investigates the operation of intellectual property law in this area and its effect on prices, investment, research and the availability of new drugs. The principal focus is on the United Kingdom but the conclusions reached may be validly applied to other jurisdictions. Each chapter is devoted to a specific branch of the law with a view to demonstrating how its exploitation by pharmaceutical firms has operated in the detriment of the public by virtually eliminating competition and thereby increasing prices. The unique nature of the pharmaceutical industry renders the desirability of exclusive rights in this area highly questionable and the abolition or curtailment of all forms of protection for pharmaceutical products is advocated.

Degree

thesis:*
Name thesis:degree_name
Master of Laws - LLM
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Law
Grantor dc:publisher
University of British Columbia
Year dc:date
1981

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rowland-Rouse, Jacqueline

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/24521

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Rowland-Rouse, Jacqueline. The strategic use of intellectual and industrial property laws to maintain and extend a dominant position in the pharmaceutical industry. master's thesis, University of British Columbia, 1981. http://hdl.handle.net/2429/24521